CWS Financial Advisors LLC Sells 161 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

CWS Financial Advisors LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 19.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 684 shares of the healthcare conglomerate’s stock after selling 161 shares during the quarter. CWS Financial Advisors LLC’s holdings in UnitedHealth Group were worth $338,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Richelieu Gestion SA purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at $26,000. CGC Financial Services LLC grew its holdings in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares in the last quarter. True Wealth Design LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at $31,000. LFA Lugano Financial Advisors SA grew its holdings in shares of UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares in the last quarter. Finally, Red Tortoise LLC grew its holdings in shares of UnitedHealth Group by 45.1% in the first quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock valued at $36,000 after purchasing an additional 23 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.4 %

UnitedHealth Group stock traded down $1.88 during trading hours on Friday, reaching $488.01. The stock had a trading volume of 3,498,996 shares, compared to its average volume of 4,448,744. The company has a market cap of $449.16 billion, a price-to-earnings ratio of 29.83, a PEG ratio of 1.44 and a beta of 0.60. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. The business’s 50 day moving average price is $498.46 and its 200-day moving average price is $500.70. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm’s revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the company posted $6.26 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.55 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.72%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio is 51.34%.

Wall Street Analyst Weigh In

Several research firms have commented on UNH. JPMorgan Chase & Co. lifted their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price objective for the company in a research note on Wednesday, June 5th. Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Royal Bank of Canada dropped their price objective on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. Finally, Truist Financial reissued a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Three analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.